Fetal therapy.
In the past year, the results of the European trial comparing chorionic villus sampling and amniocentesis have been published, supporting the findings of the Canadian Collaborative Study of an increased risk associated with chorionic villus sampling. The reporting of an increase in limb reduction abnormalities with chorionic villus sampling before 9 weeks has made us review our current practice. Other developments covered by this review include the management of mild cerebral ventriculomegaly, the treatment of tachyarrhythmias, and developments in fetal surgery. Throughout, the needs for continued collaboration, pooling of data, and the formation of international registers to extend the database from which both doctors and patients may benefit are highlighted.
Hurley
P A
PA
University College and Middlesex School of Medicine, London, UK.
Rodeck
C H
CH
D000649:Amniocentesis / Q000592:standards; D015193:Chorionic Villi Sampling / Q000592:standards; D005314:Embryonic and Fetal Development; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005315:Fetal Diseases / Q000175:diagnosis / Q000601:surgery / Q000628:therapy; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D011247:Pregnancy; D016216:Ultrasonography, Prenatal / Q000592:standards